Pretium Resources Inc. has plunged more than 50 percent in Toronto in the past five weeks after a dispute over how much gold is at a property in British Columbia fuels speculation the deposit is less promising than previously estimated.
BioLineRx Ltd., the Israeli drugmaker that last reported a profit in 2010, expects revenue from royalty payments to grow next year on prospects for drug approvals, according to Chief Executive Officer Kinneret Savitsky.
ClickSoftware Technologies Ltd., the Israeli developer whose largest investor is George Soros’s fund, tumbled in New York as the departure of its co-chief executive officer raised concern about the company’s outlook.
Dendreon Corp. won approval for its only product, the prostate cancer vaccine Provenge, concluding a three-year battle with U.S. regulators to introduce the first therapy to train the body’s immune system to destroy tumors.
Focus Media Holding Ltd., a Chinese advertising company, agreed to be bought by a consortium of investors led by Carlyle Group LP in a $3.7 billion deal that will be the country’s largest leveraged buyout.
Muddy Waters LLC, whose analyst reports triggered $7 billion in losses for Chinese stocks, used an unlikely secret weapon for its research: the public website of the U.S. Securities and Exchange Commission.
Chinese equities in New York climbed to a seven-month high after the World Bank boosted China’s 2013 economic growth forecast. Focus Media Holding Ltd. jumped after agreeing to go private in China’s biggest leveraged buyout.